Adapting analytics and quality control in cell therapy manufacturing to ensure adequate safety, purity, and potency of final products
25 Feb 2025
C & G Manufacturing
- How can manufacturers build an effective potency assurance strategy to guarantee the consistency and efficacy of cell therapy products?
- What steps are essential for thorough drug product characterization to evaluate the safety, purity, and potency of cell and gene therapy (CGT) products?
- Why is it critical to establish a clear link between critical process parameters (CPPs) and critical quality attributes (CQAs) in developing a robust manufacturing process?
